N/A
N=539
Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments
Wound Healing Disorder · Impaired Wound Healing · Abdominal Wound Healing Disorder · Abdominal Wound Healing Impairment · Acute Postsurgical Subcutaneous Wound
Bottom Line
View on ClinicalTrials.gov: NCT01528033 ↗Enrolled (actual)
539
Serious AEs
7.8%
Results posted
Jun 2020
Primary outcome: Primary: Time to Complete Wound Closure — 36.1; 39.1 Days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Vacuum Assisted Closure® (Device); Standard conventional wound therapy (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Witten/Herdecke
- Primary completion
- Mar 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time to Complete Wound Closure |
36.1; 39.1 | — |
| SECONDARY Incidence of Confirmed and Verified Wound Closure |
92; 54 | — |
| SECONDARY Recurrence |
0; 0 | — |
Summary
This clinical study is performed in several German, Dutch and Belgian hospitals to evaluate the efficacy of Vacuum Assisted Closure® (V.A.C.®) for the treatment of postsurgical abdominal wound healing impairments after surgery. Therefore the underlying layer of fibrous tissue that permeates the internal organs must be intact.
Main outcome measure is the time until complete wound closure that sustained for a minimum of 14 days. Furthermore the therapy options will be examined regarding several other clinical, safety, patient reported and economic parameters.
Patients will be assigned equally and by chance to both treatment groups. Study participants as well as the attending doctors and nurses will be informed about the assignment to the respective treatment arm.
The primary outcome measure and some of the secondary parameters like reappearance of the wound and the development of the wound size over time, examined within an active study treatment time of 42 days, will be photographed and analysed under the use of a central computer system. The central analysing personal will not be informed about patient details or therapy allocation.
Patients with at first closed belly wounds with wound healing disorder in the postoperative course after surgery without an opening of the underlying layer of fibrous tissue are eligible to be included in the trial if the diagnosis of a wound healing impairment in the postoperative course is manifested as a wound with spontaneous dehiscence, a wound that requires an active reopening of the suture by the treating physician or a wound that cannot be closed by primary intention and requires further treatment to achieve permanent closure.
Study participants will be selected and enrolled within clinical surgical departments which provide the respective personal, structural and scientific background for the conduction of the trial project.
Trial therapy will be started in-hospital and may be continued in ambulatory care. It is very important to examine the therapy options also in the ambulant care setting thus study participants with good health who are able to continue the specific wound treatment in ambulant should be transferred to the ambulant service as soon as possible.
Eligibility Criteria
Inclusion Criteria
- Written informed consent
- Post-surgical subcutaneous abdominal wound healing impairment
- Minimum wound size eligible for the application of the randomized treatment- Inclusion, randomization, adequate wound pre-treatment (Debridement) and start of therapy within 48 hours after reopening of the wound, diagnosis for nonclosable wound or in case of spontaneous wound dehiscence
Exclusion Criteria
- Age < 18
- Noncompliance with study procedures, visit schedule and follow up
- Pregnancy
- Present or nonclosable defect of the abdominal fascia
- Any pre-existing or ongoing organ system failure, that cannot be stabilized or solved by appropriate medical treatment
- Necrotic tissue with eschar present
- Non-enteric and unexplored fistulas
- Malignancy of the wound
- Use of any other device based on the principle of negative pressure wound therapy on the study wound within ≤ 8 days prior to screening
- Competing therapies or procedures
- Simultaneous participation in other clinical trials
Data sourced from ClinicalTrials.gov (NCT01528033). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.